BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32667830)

  • 1. Pictorial review of whole body MRI in myeloma: emphasis on diffusion-weighted imaging.
    Hameed M; Sandhu A; Soneji N; Amiras D; Rockall A; Messiou C; Wallitt K; Barwick TD
    Br J Radiol; 2020 Nov; 93(1115):20200312. PubMed ID: 32667830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How do we image patients with multiple myeloma and precursor states?
    Chakraborty R; Hillengass J; Lentzsch S
    Br J Haematol; 2023 Nov; 203(4):536-545. PubMed ID: 37217164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma.
    Dutoit JC; Verstraete KL
    Skeletal Radiol; 2017 Jun; 46(6):733-750. PubMed ID: 28289855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma.
    Mesguich C; Hulin C; Latrabe V; Lascaux A; Bordenave L; Hindié E; Marit G
    Ann Hematol; 2020 Dec; 99(12):2869-2880. PubMed ID: 32951093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of early treatment response on MRI in multiple myeloma: Comparative study of whole-body diffusion-weighted and lumbar spinal MRI.
    Takasu M; Kondo S; Akiyama Y; Takahashi Y; Maeda S; Baba Y; Kawase T; Ichinohe T; Awai K
    PLoS One; 2020; 15(2):e0229607. PubMed ID: 32106239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of whole-body MRI for treatment response assessment in multiple myeloma: comparison between clinical response and imaging response.
    Park HY; Kim KW; Yoon MA; Lee MH; Chae EJ; Lee JH; Chung HW; Yoon DH
    Cancer Imaging; 2020 Jan; 20(1):14. PubMed ID: 32000858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interobserver agreement of whole-body magnetic resonance imaging is superior to whole-body computed tomography for assessing disease burden in patients with multiple myeloma.
    Lai AYT; Riddell A; Barwick T; Boyd K; Rockall A; Kaiser M; Koh DM; Saffar H; Yusuf S; Messiou C
    Eur Radiol; 2020 Jan; 30(1):320-327. PubMed ID: 31267214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma.
    Narquin S; Ingrand P; Azais I; Delwail V; Vialle R; Boucebci S; Tasu JP
    Diagn Interv Imaging; 2013 Jun; 94(6):629-36. PubMed ID: 23683788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of multiple myeloma and metastases: Use of axial diffusion-weighted MR imaging in addition to standard MR imaging at 3T.
    Park GE; Jee WH; Lee SY; Sung JK; Jung JY; Grimm R; Son Y; Paek MY; Min CK; Ha KY
    PLoS One; 2018; 13(12):e0208860. PubMed ID: 30557373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current concepts in tumor imaging with whole-body MRI with diffusion imaging (WB-MRI-DWI) in multiple myeloma and lymphoma.
    Stecco A; Buemi F; Iannessi A; Carriero A; Gallamini A
    Leuk Lymphoma; 2018 Nov; 59(11):2546-2556. PubMed ID: 29431555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.
    Dammacco F; Rubini G; Ferrari C; Vacca A; Racanelli V
    Clin Exp Med; 2015 Feb; 15(1):1-18. PubMed ID: 25218739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRI.
    Zambello R; Crimì F; Lico A; Barilà G; Branca A; Guolo A; Varin C; Vezzaro R; Checuz L; Scapin V; Berno T; Pizzi M; Ponzoni A; De Biasi E; Vio S; Semenzato G; Zucchetta P; Lacognata C
    Ann Hematol; 2019 Mar; 98(3):679-689. PubMed ID: 30539276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted whole-body MRI for evaluation of early response in multiple myeloma.
    Lacognata C; Crimì F; Guolo A; Varin C; De March E; Vio S; Ponzoni A; Barilà G; Lico A; Branca A; De Biasi E; Gherlinzoni F; Scapin V; Bissoli E; Berno T; Zambello R
    Clin Radiol; 2017 Oct; 72(10):850-857. PubMed ID: 28587715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of whole-body diffusion-weighted magnetic resonance imaging for the diagnosis of and therapeutic response in multiple myeloma].
    Puskás T; Henits I
    Orv Hetil; 2014 Aug; 155(31):1241-5. PubMed ID: 25095285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Whole-Body DWI and
    Chen J; Li C; Tian Y; Xiao Q; Deng M; Hu H; Wen B; He Y
    AJR Am J Roentgenol; 2019 Sep; 213(3):514-523. PubMed ID: 31166755
    [No Abstract]   [Full Text] [Related]  

  • 16. Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?
    Pawlyn C; Fowkes L; Otero S; Jones JR; Boyd KD; Davies FE; Morgan GJ; Collins DJ; Sharma B; Riddell A; Kaiser MF; Messiou C
    Leukemia; 2016 Jun; 30(6):1446-8. PubMed ID: 26648535
    [No Abstract]   [Full Text] [Related]  

  • 17. Frequency, distribution and clinical management of incidental findings and extramedullary plasmacytomas in whole body diffusion weighted magnetic resonance imaging in patients with multiple myeloma.
    Wale A; Pawlyn C; Kaiser M; Messiou C
    Haematologica; 2016 Apr; 101(4):e142-4. PubMed ID: 26819048
    [No Abstract]   [Full Text] [Related]  

  • 18. Relevance of diffusion-weighted imaging with background body signal suppression for staging, prognosis, morphology, treatment response, and apparent diffusion coefficient in plasma-cell neoplasms: A single-center, retrospective study.
    Yamada A; Araki Y; Tanaka Y; Otsuki S; Yamada A; Moriyama M; Katagiri S; Suguro T; Asano M; Yoshizawa S; Akahane D; Furuya N; Fujimoto H; Okabe S; Gotoh M; Suzuki K; Saito K; Gotoh A
    PLoS One; 2021; 16(7):e0253025. PubMed ID: 34242226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modern radiographic imaging in multiple myeloma, what is the minimum requirement?
    Mena E; Turkbey EB; Lindenberg L
    Semin Oncol; 2022 Feb; 49(1):86-93. PubMed ID: 35190200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apparent diffusion coefficient maps integrated in whole-body MRI examination for the evaluation of tumor response to chemotherapy in patients with multiple myeloma.
    Bonaffini PA; Ippolito D; Casiraghi A; Besostri V; Franzesi CT; Sironi S
    Acad Radiol; 2015 Sep; 22(9):1163-71. PubMed ID: 26182979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.